Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New treatments for multiple sclerosis: at what long-term risk?
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Cytomegalovirus associated transverse myelitis in an immunocompetent host with DNA detection in cerebrospinal fluid; a case report.
Induction and molecular signature of pathogenic T(H)17 cells.
Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Gilenya Safety Update
Effect of comorbidity on mortality in multiple sclerosis.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
[Current aspects of therapy conversion for multiple sclerosis].
A basic overview of multiple sclerosis immunopathology.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Cortical excitability changes over time in progressive multiple sclerosis.
Elevated moral condemnation of third-party violations in multiple sclerosis patients.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
[Spinal segmental myoclonus in multiple sclerosis (case report).]
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Aquaporin water channels in the nervous system.

Pages